ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients

Esophageal and Esophagogastric Junction Cancers

(2017) Jaffer A. Ajani et al.   Journal of the National Comprehensive Cancer Network

Loss of TGF-  Adaptor  2SP Activates Notch Signaling and SOX9 Expression in Esophageal Adenocarcinoma

(2013) S. Song et al.   CANCER RESEARCH

ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome

(2012) Yu-Chi Wang et al.   AMERICAN JOURNAL OF PATHOLOGY

Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer

(2012) J. A. Ajani et al.   ANNALS OF ONCOLOGY

Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort

(2012) N. K. S. Cheedella et al.   ANNALS OF ONCOLOGY

The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends

(2012) A. P. Thrift et al.   ANNALS OF ONCOLOGY

Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity

(2012) GONG ZHANG et al.   Molecular Medicine Reports

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

(2011) A. D. Steg et al.   CLINICAL CANCER RESEARCH

Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China

(2011) Y. Wang et al.   DISEASES OF THE ESOPHAGUS

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

(2011) S. Ricardo et al.   JOURNAL OF CLINICAL PATHOLOGY

Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers

(2011) Giang Huong Nguyen et al.   Cancers

Mantle cell lymphoma activation enhances bortezomib sensitivity

(2010) S. K. Brennan et al.   BLOOD

High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition

(2010) Ola Awad et al.   PLoS One

Galectin-3 Mediates Nuclear β-Catenin Accumulation and Wnt Signaling in Human Colon Cancer Cells by Regulation of Glycogen Synthase Kinase-3β Activity

(2009) Shumei Song et al.   CANCER RESEARCH

Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

(2009) William H. Allum et al.   JOURNAL OF CLINICAL ONCOLOGY

Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

(2009) F. Jiang et al.   MOLECULAR CANCER RESEARCH

Worldwide esophageal cancer collaboration

(2008) T. W. Rice et al.   DISEASES OF THE ESOPHAGUS

ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells

(2008) Jan S Moreb et al.   Molecular Cancer